Arbutus Announces Resignation of Board Member
WARMINSTER, Pa., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage
Globe Newswire27-01-2023, 19:32
ESB Scotland Signs Three Letters of Intent for Projects Utilizing American Energy Storage Innovations’ TeraStor 12-09-2024, 02:42